19-9610228-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152289.3(ZNF561):āc.1433A>Gā(p.Glu478Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000758 in 1,606,900 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152289.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF561 | ENST00000302851.8 | c.1433A>G | p.Glu478Gly | missense_variant | 6/6 | 1 | NM_152289.3 | ENSP00000303915.3 | ||
ZNF561 | ENST00000424629.5 | c.1226A>G | p.Glu409Gly | missense_variant | 5/5 | 2 | ENSP00000393074.1 | |||
ZNF561 | ENST00000326044 | c.*1077A>G | 3_prime_UTR_variant | 5/5 | 2 | ENSP00000370284.2 | ||||
ZNF561 | ENST00000444802.5 | n.*330+3793A>G | intron_variant | 5 | ENSP00000402974.1 |
Frequencies
GnomAD3 genomes AF: 0.000493 AC: 75AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000639 AC: 157AN: 245858Hom.: 0 AF XY: 0.000624 AC XY: 83AN XY: 133054
GnomAD4 exome AF: 0.000786 AC: 1143AN: 1454672Hom.: 1 Cov.: 30 AF XY: 0.000745 AC XY: 539AN XY: 723350
GnomAD4 genome AF: 0.000493 AC: 75AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.000511 AC XY: 38AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.1433A>G (p.E478G) alteration is located in exon 6 (coding exon 5) of the ZNF561 gene. This alteration results from a A to G substitution at nucleotide position 1433, causing the glutamic acid (E) at amino acid position 478 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at